Articles by Disease (Hematological Malignancies)

Challenging the Current Approaches to Multiple Myeloma-Related Bone Disease: From Bisphosphonates to Target Therapy

Journal: Current Cancer Drug Targets
Volume: 9
Page: 854-870
Author(s): P. Tassone, P. Tagliaferri, M. Rossi, T. Calimeri, A. Bulotta, A. Abbruzzese, M. Caraglia and P. Neri

The Role of Major Histocompatibility Complex Polymorphisms in the Incidence and Outcome of Non-Hodgkin Lymphoma

Journal: Current Immunology Reviews (Discontinued)
Volume: 5
Page: 300-310
Author(s): Jacek Nowak, Przemyslaw Juszczynski and Krzysztof Warzocha

Ansamycin Inhibitors of Hsp90: Natures Prototype for Anti-Chaperone Therapy

Journal: Current Topics in Medicinal Chemistry
Volume: 9
Page: 1386-1418
Author(s): James R. Porter, Jie Ge, John Lee, Emmanuel Normant and Kip West

Update on Hsp90 Inhibitors in Clinical Trial

Journal: Current Topics in Medicinal Chemistry
Volume: 9
Page: 1479-1492
Author(s): Y. S. Kim, S. V. Alarcon, S. Lee, M.-J. Lee, G. Giaccone, L. Neckers and J. B. Trepel

Challenges in the Management of Paediatric Febrile Neutropenia

Journal: Current Pediatric Reviews
Volume: 5
Page: 229-233
Author(s): Bob Phillips, Roderick Skinner, Sheila M. Lane and Julia C. Chisholm

Selective Chemokine Receptor-Targeted Depletion of Pathological Cells as A Therapeutic Strategy for Inflammatory, Allergic and Autoimmune Diseases

Journal: Recent Patents on Inflammation & Allergy Drug Discovery
Volume: 3
Page: 177-187
Author(s): John R. McDonald

Beneficial and Adverse Effects of Molecularly Targeted Therapies for Acute Promyelocytic Leukemia in Central Nervous System

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 8
Page: 387-392
Author(s): Sumimasa Nagai, Tsuyoshi Takahashi and Mineo Kurokawa